Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

GlucoTrack, Inc. Common Stock (GCTK)

Surgical & Medical Instruments & Apparatus

https://www.glucotrack.com

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It also focuses on developing a wireless module for transmission of measurement data captured by the GlucoTrack model DF-F to a cloud-based server.

301 RT 17 NORTH, SUITE 800
RUTHERFORD, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/10/2000

Market Cap

10,902,096

Shares Outstanding

20,890,000

Weighted SO

20,892,193

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

NXGL --.--%

AVGR --.--%

STSS --.--%

LUCY --.--%

GMVD --.--%

POAI --.--%

MBOT --.--%

PDEX --.--%

ZJYL --.--%

Beta

0.0570

Last Div

0.0000

Range

0.665-4.95

Chg

-0.0300

Avg Vol

17929

Mkt Cap

10902096

Exch

NASDAQ

Country

IL

Phone

972 8 675 7878

DCF Diff

0.9653

DCF

1.0347

Div Yield

0.0000

P/S

259.5737

EV Multiple

-1.4435

P/FV

-3.3131

Div Yield %

0.0000

P/E

-1.4328

PEG

0.0029

Payout

0.0000

Current Ratio

0.1208

Quick Ratio

0.1208

Cash Ratio

0.0434

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

21247.6596

CCC

-21247.6596

Gross Margin

-0.1190

Op Margin

-181.8095

Pretax Margin

-181.0714

Net Margin

-181.0714

Eff Tax Rate

0.0054

ROA

-12.5082

ROE

-5.1394

ROCE

2.5020

NI/EBT

1.0000

EBT/EBIT

0.9959

EBIT/Rev

-181.8095

Debt Ratio

0.3750

D/E

-0.0693

LT Debt/Cap

-0.0617

Total Debt/Cap

-0.0745

Int Coverage

293.6923

CF/Debt

-40.0877

Equity Multi

-0.1849

Rec Turnover

0.0000

Pay Turnover

0.0172

Inv Turnover

0.0000

FA Turnover

0.2675

Asset Turnover

0.0691

OCF/Share

-1.6692

FCF/Share

-1.6821

Cash/Share

0.0290

OCF/Sales

-217.6190

FCF/OCF

1.0078

CF Coverage

-40.0877

ST Coverage

-247.0270

CapEx Coverage

-128.7324

Div&CapEx Cov

-128.7324

P/BV

-3.3131

P/B

-3.3131

P/S

259.5737

P/E

-1.4328

P/FCF

-1.1836

P/OCF

-1.1922

P/CF

-1.1922

PEG

0.0029

P/S

259.5737

EV Multiple

-1.4435

P/FV

-3.3131

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 02, 12:33 GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR GlobeNewswire Inc. Jan 02, 12:33 GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR GlobeNewswire Inc. Nov 30, 17:39 GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

Revenue Product Segmentation